Muhammad Shurafa

1.3k citations
29 papers · 913 · h-index 12

Impact in

  • Hematology top 2%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 5%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Hemophilia Treatment and Research 6
    • Acute Myeloid Leukemia Research 5
    • Platelet Disorders and Treatments 4
    • Blood Coagulation and Thrombosis Mechanisms 3
    • Chronic Lymphocytic Leukemia Research 6
    • Hemoglobinopathies and Related Disorders 4

Muhammad Shurafa

28 papers receiving 894 citations

Peers

Muhammad Shurafa
Comparison fields: 5 of 70
  • Hematology 383
  • Genetics 247
  • Oncology 287
  • Pathology and Forensic Medicine 124
  • Gastroenterology 32
Replace Hawk Kim with:
Hawk Kim South Korea
Carlos Chiattone Brazil
Peter A.W. te Boekhorst Netherlands
Joan Besalduch Spain
Moritz Binder United States
Chris S.R Hatton United Kingdom
Nicoletta Crescenzio Italy
José M. Hernández Spain
Lucy S. Hodge United States
Yoshiaki Okuno Japan
Muhammad Shurafa relative to Hawk Kim South Korea Hawk Kim's profile →
Citations per field
00.5×1.5×2.1×
Hawk Kim · 1×
Citations per year

Countries citing papers authored by Muhammad Shurafa

Since Specialization
Citations

This map shows the geographic impact of Muhammad Shurafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Shurafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Shurafa more than expected).

Fields of papers citing papers by Muhammad Shurafa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Shurafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Shurafa. The network helps show where Muhammad Shurafa may publish in the future.

Co-authors

The 25 scholars most cited alongside Muhammad Shurafa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Muhammad Shurafa Line = papers co-authored together Muhammad Shurafa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2001301
2 2001102
3 200092
4
Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
200078
5 198742
6 199841
7 200039
8 200734
9 200431
10 200031
11 200116
12
Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial.
199516
13 200010
14 20049
15 20039
16 20048
17 19998
18 19878
19
Factor VII G331D: a variant molecule involving replacement of a residue in the substrate-binding region of the catalytic domain.
19968
20 19877

About Muhammad Shurafa

Muhammad Shurafa is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Surgery, having authored 29 papers that have together received 913 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Myeloid Leukemia Research (5 papers), Platelet Disorders and Treatments (4 papers), Hemoglobinopathies and Related Disorders (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Polyomavirus and related diseases (2 papers). The work is most often cited by research in Hematology (383 citations), Genetics (247 citations), Oncology (287 citations), Pathology and Forensic Medicine (124 citations) and Gastroenterology (32 citations). Muhammad Shurafa has collaborated with scholars based in United States. Frequent co-authors include Frederick R. Appelbaum, Kenneth J. Kopecky, Cheryl L. Willman, David R. Head, James H. Doroshow, Marilyn L. Slovak, Chatchada Karanes, Harry E. Hynes, Diane L. Persons and Robert T. Dorr. Their work appears in journals such as Blood, American Journal of Hematology, Archives of Pathology & Laboratory Medicine, Genes Chromosomes and Cancer and Haemophilia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact